Hims & Hers Health Faces Regulatory Challenges
Cashu Finance·5 min read

TL;DR
- Hims & Hers faces significant regulatory scrutiny.
- Stock price dropped 14% post-FTC lawsuit announcement.
- Company strategies undergoing reevaluation amidst legal challenges.
Hims & Hers Health, Inc. (HIMS) is currently navigating turbulent waters marked by significant regulatory scrutiny that threatens both its operational framework and market performance. As a digital health company specializing in telehealth services and a range of health products, Hims & Hers has experienced substantial challenges following a lawsuit filed by the Federal Trade Commission (FTC). This piece explores the current scenario for Hims & Hers, examining the implications these regulatory pressures bear on its business strategy, operational sustainability, and investor relations.
The FTC Lawsuit and Its Impact
In an alarming turn of events for Hims & Hers, the FTC filed a lawsuit on July 29, 2026, accusing the company of deceptive marketing practices. The lawsuit centers around allegations that Hims & Hers misled consumers regarding the cost of its prescription services after users completed their intake forms. Specifically, the FTC contends that consumers were not adequately informed about costs before being billed, undermining the perceived value of pre-consultation with medical professionals. This has not only raised questions about consumer trust but also resulted in an immediate share price drop of 14%, erasing approximately $970 million from the company's market valuation. This drop highlights the immediate fallout from regulatory scrutiny.
The company's challenges didn’t stop with the initial lawsuit. Ongoing investigations have revealed deeper issues related to Hims & Hers’ handling of sensitive consumer health data, further complicating its operational landscape. As reported in an earlier article, this regulatory minefield has shaken investor confidence, creating an atmosphere fraught with uncertainty and volatility around the stock's performance (source).

